newsfilter
← Latest News
GlobeNewswire·

Lakefront to Present at the 2026 Jefferies Global Healthcare Conference in London

  • Lakefront Biotherapeutics NV (LKFT) will host a fireside chat at the 2026 Jefferies Global Healthcare Conference in London on Tuesday, November 17, 2026, at 2:00 pm GMT (9:00 am ET).
  • A live webcast of the presentation will be accessible on the company's Investors page, with a replay available for up to 90 days after the event.
  • Lakefront is a clinical-stage biotechnology company focused on immunology & inflammation, anchored by gamgertamig, a potential first-in-class BCMAxCD3 T-cell engager for autoimmune diseases.
  • The company leverages deal-making expertise & operational flexibility to advance high-quality assets for patients with serious diseases.
  • Investor relations contacts include Sherri Spear (+1 412 522 6418) & Richie Livingston (+1 312 636 7072).
  • The press release includes forward-looking statements subject to risks & uncertainties detailed in SEC filings, which may cause actual results to differ materially from expectations.
Company
Lakefront Biotherapeutics
Keywords
Brussels Stock Exchange:LKFT, Lakefront Biotherapeutics